Monica Radu

706 total citations · 1 hit paper
7 papers, 385 citations indexed

About

Monica Radu is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Monica Radu has authored 7 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Hepatology and 1 paper in Infectious Diseases. Recurrent topics in Monica Radu's work include Hepatitis C virus research (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (3 papers). Monica Radu is often cited by papers focused on Hepatitis C virus research (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (3 papers). Monica Radu collaborates with scholars based in Romania, United Kingdom and Greece. Monica Radu's co-authors include Oliver Lenz, Gregory J. Dore, Ronald Kalmeijer, Michael Fried, Sivi Ouwerkerk‐Mahadevan, Maria Beumont‐Mauviel, Ira M. Jacobson, Monika Peeters, Graham R. Foster and Antonio Craxı̀ and has published in prestigious journals such as The Lancet, Gastroenterology and Liver International.

In The Last Decade

Monica Radu

7 papers receiving 376 citations

Hit Papers

Simeprevir with pegylated interferon alfa 2a plus ribavir... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monica Radu Romania 5 372 351 90 31 10 7 385
Cecilia Marrocco Italy 11 466 1.3× 454 1.3× 65 0.7× 15 0.5× 5 0.5× 15 500
K.V. Kowdley United States 10 308 0.8× 280 0.8× 56 0.6× 29 0.9× 4 0.4× 31 320
Annika Kau Germany 3 372 1.0× 371 1.1× 43 0.5× 29 0.9× 4 0.4× 4 410
Linda Baher United States 3 277 0.7× 248 0.7× 81 0.9× 32 1.0× 8 0.8× 3 288
E.J. Lawitz United States 12 393 1.1× 371 1.1× 93 1.0× 37 1.2× 11 1.1× 27 409
S. Roberts Australia 10 276 0.7× 250 0.7× 69 0.8× 24 0.8× 8 0.8× 19 286
Rie Mineta Japan 11 403 1.1× 381 1.1× 96 1.1× 19 0.6× 15 1.5× 17 428
Peter Varunok United States 4 537 1.4× 484 1.4× 149 1.7× 37 1.2× 13 1.3× 4 557
Tolga Baykal United States 3 406 1.1× 369 1.1× 113 1.3× 25 0.8× 10 1.0× 5 418
M.J. Jimenez-Exposito Spain 7 258 0.7× 275 0.8× 91 1.0× 18 0.6× 4 0.4× 13 318

Countries citing papers authored by Monica Radu

Since Specialization
Citations

This map shows the geographic impact of Monica Radu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Radu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Radu more than expected).

Fields of papers citing papers by Monica Radu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Radu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Radu. The network helps show where Monica Radu may publish in the future.

Co-authorship network of co-authors of Monica Radu

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Radu. A scholar is included among the top collaborators of Monica Radu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Radu. Monica Radu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Bremer, Birgit, Olympia E. Anastasiou, Svenja Hardtke, et al.. (2020). Residual low HDV viraemia is associated HDV RNA relapse after PEG‐IFNa‐based antiviral treatment of hepatitis delta: Results from the HIDIT‐II study. Liver International. 41(2). 295–299. 17 indexed citations
2.
Anastasiou, Olympia E., Cihan Yurdaydın, Benjamin Maasoumy, et al.. (2020). A transient early HBV‐DNA increase during PEG‐IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV‐RNA and HBsAg reduction. Journal of Viral Hepatitis. 28(2). 410–419. 6 indexed citations
3.
Enciu, Octavian, et al.. (2016). Primary peritoneal tuberculosis, a forgotten localization. Case report. Indian Journal of Tuberculosis. 65(3). 257–259. 1 indexed citations
4.
Jacobson, Ira M., Gregory J. Dore, Graham R. Foster, et al.. (2014). Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet. 384(9941). 403–413. 333 indexed citations breakdown →
5.
Jacobson, Ira M., Gregory J. Dore, Graham R. Foster, et al.. (2013). Sa2072 Simeprevir (TMC435) With Peginterferon/Ribavirin for Chronic HCV Genotype-1 Infection in Treatment-Nai;auve Patients: Results From QUEST-1, a Phase III Trial. Gastroenterology. 144(5). S–374. 12 indexed citations
6.
Căruntu, Florin Alexandru, et al.. (2013). Use of quantitative serum HBsAg for optimization of therapy in chronic hepatitis B patients treated with pegylated interferon alfa-2a: a Romanian cohort study.. PubMed. 22(1). 27–32. 12 indexed citations
7.
Farkas, Anna, Monica Radu, Mátyás Présing, et al.. (2008). Monitoring pollution in River Mures, Romania, Part I: The limitation of traditional methods and community response. River Systems. 18(1-2). 91–106. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026